These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 31223461)

  • 1. Discovery of SHR1653, a Highly Potent and Selective OTR Antagonist with Improved Blood-Brain Barrier Penetration.
    Li X; Zhang Z; Chen Y; Wan H; Sun J; Wang B; Feng B; Hu B; Shi X; Feng J; Zhang L; He F; Bai C; Zhang L; Tao W
    ACS Med Chem Lett; 2019 Jun; 10(6):996-1001. PubMed ID: 31223461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cligosiban, A Novel Brain-Penetrant, Selective Oxytocin Receptor Antagonist, Inhibits Ejaculatory Physiology in Rodents.
    Wayman C; Russell R; Tang K; Weibly L; Gaboardi S; Fisher L; Allers K; Jackson M; Hawcock T; Robinson N; Wilson L; Gupta J; Casey J; Gibson KR
    J Sex Med; 2018 Dec; 15(12):1698-1706. PubMed ID: 30527053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent and selective oxytocin receptor agonists without disulfide bridges.
    Adachi Y; Sakimura K; Shimizu Y; Nakayama M; Terao Y; Yano T; Asami T
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2331-2335. PubMed ID: 28438540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modeling of interactions of the non-peptide antagonist YM087 with the human vasopressin V1a, V2 receptors and with oxytocin receptors.
    Giełdoń A; Kaźmierkiewicz R; Slusarz R; Ciarkowski J
    J Comput Aided Mol Des; 2001 Dec; 15(12):1085-104. PubMed ID: 12160092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist.
    Ring RH; Schechter LE; Leonard SK; Dwyer JM; Platt BJ; Graf R; Grauer S; Pulicicchio C; Resnick L; Rahman Z; Sukoff Rizzo SJ; Luo B; Beyer CE; Logue SF; Marquis KL; Hughes ZA; Rosenzweig-Lipson S
    Neuropharmacology; 2010 Jan; 58(1):69-77. PubMed ID: 19615387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxytocin receptor pattern of expression in primary lung cancer and in normal human lung.
    Péqueux C; Breton C; Hagelstein MT; Geenen V; Legros JJ
    Lung Cancer; 2005 Nov; 50(2):177-88. PubMed ID: 16043261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative distribution of vasopressin V1b and oxytocin receptor messenger ribonucleic acids in brain.
    Vaccari C; Lolait SJ; Ostrowski NL
    Endocrinology; 1998 Dec; 139(12):5015-33. PubMed ID: 9832441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of Oxytocin Analogs.
    Wiśniewski K
    Methods Mol Biol; 2019; 2001():235-271. PubMed ID: 31134574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective and non-selective OT receptor agonists induce different locomotor behaviors in male rats via central OT receptors and peripheral V1a receptors.
    Wolfe M; Wisniewska H; Tariga H; Ibanez G; Collins JC; Wisniewski K; Qi S; Srinivasan K; Hargrove D; Lindstrom BF
    Neuropeptides; 2018 Aug; 70():64-75. PubMed ID: 29807652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, Safety, and Tolerability of Single Oral Doses of a Novel Oxytocin Receptor Antagonist-Cligosiban-in Development for Premature Ejaculation: Three Randomized Clinical Trials in Healthy Subjects.
    Osterloh IH; Muirhead GJ; Sultana S; Whaley S; van den Berg F; Atiee G
    J Sex Med; 2018 Nov; 15(11):1547-1557. PubMed ID: 30341006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Oxytocin Antagonist Cligosiban Prolongs Intravaginal Ejaculatory Latency and Improves Patient-Reported Outcomes in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Trial (PEPIX).
    McMahon C; Althof S; Rosen R; Giuliano F; Miner M; Osterloh IH; Muirhead GJ; Harty B;
    J Sex Med; 2019 Aug; 16(8):1178-1187. PubMed ID: 31351659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WAY 267,464, a non-peptide oxytocin receptor agonist, impairs social recognition memory in rats through a vasopressin 1A receptor antagonist action.
    Hicks C; Ramos L; Reekie TA; Narlawar R; Kassiou M; McGregor IS
    Psychopharmacology (Berl); 2015 Aug; 232(15):2659-67. PubMed ID: 25761839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Oxytocin Antagonist Cligosiban Fails to Prolong Intravaginal Ejaculatory Latency in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Phase IIb trial (PEDRIX).
    Althof S; Osterloh IH; Muirhead GJ; George K; Girard N;
    J Sex Med; 2019 Aug; 16(8):1188-1198. PubMed ID: 31351660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxytocin and vasopressin receptor distributions in a solitary and a social species of tuco-tuco (Ctenomys haigi and Ctenomys sociabilis).
    Beery AK; Lacey EA; Francis DD
    J Comp Neurol; 2008 Apr; 507(6):1847-59. PubMed ID: 18271022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oxytocin receptor and beta2-adrenoceptor blockade on myometrial oxytocin receptors in parturient rats.
    Engstrøm T; Bratholm P; Vilhardt H; Christensen NJ
    Biol Reprod; 1999 Feb; 60(2):322-9. PubMed ID: 9915997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxytocin- and vasopressin-induced growth of human small-cell lung cancer is mediated by the mitogen-activated protein kinase pathway.
    Péqueux C; Keegan BP; Hagelstein MT; Geenen V; Legros JJ; North WG
    Endocr Relat Cancer; 2004 Dec; 11(4):871-85. PubMed ID: 15613460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive reinforcing effect of oxytocin microinjection in the rat central nucleus of amygdala.
    László K; Kovács A; Zagoracz O; Ollmann T; Péczely L; Kertes E; Lacy DG; Lénárd L
    Behav Brain Res; 2016 Jan; 296():279-285. PubMed ID: 26386304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [
    Vidal B; Karpenko IA; Liger F; Fieux S; Bouillot C; Billard T; Hibert M; Zimmer L
    Nucl Med Biol; 2017 Dec; 55():1-6. PubMed ID: 28917111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxytocin inhibits the rat medullary dorsal horn Sp5c/C1 nociceptive transmission through OT but not V
    García-Boll E; Martínez-Lorenzana G; Condés-Lara M; González-Hernández A
    Neuropharmacology; 2018 Feb; 129():109-117. PubMed ID: 29169960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the vasopressin V1A receptor in oxytocin modulation of methamphetamine primed reinstatement.
    Everett NA; McGregor IS; Baracz SJ; Cornish JL
    Neuropharmacology; 2018 May; 133():1-11. PubMed ID: 29353054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.